Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04517292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
ClinicalTrials.gov study NCT01025570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
ClinicalTrials.gov study NCT00217477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relap
ClinicalTrials.gov study NCT06521255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01218880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02391662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial
ClinicalTrials.gov study NCT00061451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes
ClinicalTrials.gov study NCT00192101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT00101842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00064051. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Receive
ClinicalTrials.gov study NCT00702975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment
ClinicalTrials.gov study NCT01509911. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00005093. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
ClinicalTrials.gov study NCT00475917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
ClinicalTrials.gov study NCT06181032. IPD Sharing: NO. Countries: 1. Publications: 0.
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
ClinicalTrials.gov study NCT06822010. IPD Sharing: NO. Countries: 0. Publications: 0.
Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer
ClinicalTrials.gov study NCT04984980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00064064. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
ClinicalTrials.gov study NCT00061464. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT00878163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.